Doctor profile · Federal record

Dr. Laila Rahbar, MD

Rheumatology Physician (CMS: Rheumatology) · Williamsburg, VA

  • NPI 1417140864
  • Accepts Medicare
  • MIPS 77.9 / 100 · 2023
  • 20 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
329 McLaws Cir
Williamsburg, VA 231856337
(757) 220-8579

Credentials & registration

NPPES · NUCC
NPI registered
August 2007 — 19 yrs on file
Profile last updated
November 19, 2020
Year of graduation
2006 — 20 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Virginia #0101254212

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1417140864. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
245,016
Distinct HCPCS
10
Medicare allowed
$3,991,671
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 89,320 21 $6
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 60,400 18 $5
J0897 Injection, denosumab, 1 mg 40,440 397 $23
J1745 Injection, infliximab, excludes biosimilar, 10 mg 23,217 55 $33
J1602 Injection, golimumab, 1 mg, for intravenous use 12,100 13 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 7,825 12 $42
J3245 Injection, tildrakizumab, 1 mg 4,300 13 $138
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,157 437 $8
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 975 410 $73
96372 Injection of drug or substance under skin or into muscle 859 45 $14

In context: peer comparison

Among 3 peers in Williamsburg Rheumatology Physician, average services per provider: 8,145. This provider delivers 30× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$325
Transactions
14
Manufacturers
12
Payer (manufacturer) Industry Txns Amount
Amgen INC. 2 $43.77
Fidia Pharma USA INC. 2 $33.65
Janssen Biotech, INC. 1 $32.53
Radius Health, INC. 1 $30.07
Novartis Pharmaceuticals Corporation 1 $28.83
Ucb, INC. 1 $26.87
Lilly USA, LLC 1 $26.82
Boehringer Ingelheim Pharmaceuticals, INC. 1 $25.71
Celgene Corporation 1 $22.85
AstraZeneca Pharmaceuticals Lp 1 $20.70
Pfizer INC. 1 $20.36
Genentech USA, INC. 1 $13.20

By nature of payment

Food and Beverage
$325

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,288
Patients
298
Total drug cost
$545,470
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 230 69 $11,685
Hydroxychloroquine Sulfate Generic 224 57 $9,488
Prednisone Generic 222 59 $1,545
Duloxetine Hcl Generic 109 28 $3,917
Leucovorin Calcium Generic 78 18 $1,491
Famotidine Generic 75 27 $714
Leflunomide Generic 60 14 $8,490
Enbrel Sureclick (Etanercept) Brand 43 0 $306,941
Sulfasalazine Generic 43 0 $1,307
Diclofenac Sodium Generic 42 13 $948

Frequently asked questions

Auto-generated from federal data
What is Dr. Laila Rahbar's medical specialty?
Dr. Laila Rahbar practices Rheumatology Physician in Williamsburg, VA.
Where does Dr. Laila Rahbar practice?
Dr. Laila Rahbar practices at 329 McLaws Cir, Williamsburg, VA 231856337. Office phone: 7572208579.
What is Dr. Laila Rahbar's NPI?
Dr. Laila Rahbar's National Provider Identifier (NPI) is 1417140864, issued by NPPES.
Does Dr. Laila Rahbar accept Medicare assignment?
Yes. Dr. Laila Rahbar accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Laila Rahbar commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.